Infectious Agents and Cancer Blog

ASICON 2011: Getting to zero, the Indian strategy
At ASICON Conference (December 16-18, 2011) two interviews have been taken to diffuse the current efforts pursued in INDIA to reach the recent goal established by UNAIDS on AIDS transmission: "Getting to Zero"
and the second interview:
Posted by Franco Buonaguro at 10:48 Comments (0)
The EMBLEM study: an interview to Dr Mbulaiteye.
At the recent 8th AORTIC Conference, held in Cairo on Nov 30th-trough Dec 02, Dr Mbulaiteye explained during an interview to ecancer.tv the articulation and the relevance of the EMBLEM study, which is focused on revisiting the etiopathogenesis of Burkitt's lymphoma 50 years following the first studies.
Posted by Franco Buonaguro at 00:01 Comments (0)
Interview to David Bentley
An interview by Journal Nature at Cold Spring Harbor Meeting to David Bentley (Illumina Inc.).
David gave a very interesting keynote lecture at the AfSHG on :
The advent of individual human genome sequencing.
The possibility of individual human genome sequencing opens great possibility to identify individual susceptibility to infectious diseases and to cancer as well as preventive strategies and therapeutic approaches at individual level.
Posted by Franco Buonaguro at 13:20 Comments (0)
